Literature DB >> 22707842

Detecting multiple change points in piecewise constant hazard functions.

Melody S Goodman1, Yi Li, Ram C Tiwari.   

Abstract

The National Cancer Institute (NCI) suggests a sudden reduction in prostate cancer mortality rates, likely due to highly successful treatments and screening methods for early diagnosis. We are interested in understanding the impact of medical breakthroughs, treatments, or interventions, on the survival experience for a population. For this purpose, estimating the underlying hazard function, with possible time change points, would be of substantial interest, as it will provide a general picture of the survival trend and when this trend is disrupted. Increasing attention has been given to testing the assumption of a constant failure rate against a failure rate that changes at a single point in time. We expand the set of alternatives to allow for the consideration of multiple change-points, and propose a model selection algorithm using sequential testing for the piecewise constant hazard model. These methods are data driven and allow us to estimate not only the number of change points in the hazard function but where those changes occur. Such an analysis allows for better understanding of how changing medical practice affects the survival experience for a patient population. We test for change points in prostate cancer mortality rates using the NCI Surveillance, Epidemiology, and End Results dataset.

Entities:  

Year:  2011        PMID: 22707842      PMCID: PMC3374653          DOI: 10.1080/02664763.2011.559209

Source DB:  PubMed          Journal:  J Appl Stat        ISSN: 0266-4763            Impact factor:   1.404


  4 in total

1.  Permutation tests for joinpoint regression with applications to cancer rates.

Authors:  H J Kim; M P Fay; E J Feuer; D N Midthune
Journal:  Stat Med       Date:  2000-02-15       Impact factor: 2.373

2.  Estimation of a change point in a hazard function based on censored data.

Authors:  Irène Gijbels; Ulkü Gürler
Journal:  Lifetime Data Anal       Date:  2003-12       Impact factor: 1.588

3.  Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.

Authors:  Brenda K Edwards; Martin L Brown; Phyllis A Wingo; Holly L Howe; Elizabeth Ward; Lynn A G Ries; Deborah Schrag; Patricia M Jamison; Ahmedin Jemal; Xiao Cheng Wu; Carol Friedman; Linda Harlan; Joan Warren; Robert N Anderson; Linda W Pickle
Journal:  J Natl Cancer Inst       Date:  2005-10-05       Impact factor: 13.506

4.  On testing for a constant hazard against a change-point alternative.

Authors:  D E Matthews; V T Farewell
Journal:  Biometrics       Date:  1982-06       Impact factor: 2.571

  4 in total
  10 in total

1.  Temporal changes in survival after cardiac surgery are associated with the thirty-day mortality benchmark.

Authors:  Bryan G Maxwell; Jim K Wong; D Craig Miller; Robert L Lobato
Journal:  Health Serv Res       Date:  2014-04-09       Impact factor: 3.402

2.  Improved survival modeling in cancer research using a reduced piecewise exponential approach.

Authors:  Gang Han; Michael J Schell; Jongphil Kim
Journal:  Stat Med       Date:  2013-07-30       Impact factor: 2.373

3.  Estimation in the single change-point hazard function for interval-censored data with a cure fraction.

Authors:  Bing Wang; Xiaoguang Wang; Lixin Song
Journal:  J Appl Stat       Date:  2019-06-27       Impact factor: 1.416

4.  Estimating the time interval between exposure to the World Trade Center disaster and incident diagnoses of obstructive airway disease.

Authors:  Michelle S Glaser; Mayris P Webber; Rachel Zeig-Owens; Jessica Weakley; Xiaoxue Liu; Fen Ye; Hillel W Cohen; Thomas K Aldrich; Kerry J Kelly; Anna Nolan; Michael D Weiden; David J Prezant; Charles B Hall
Journal:  Am J Epidemiol       Date:  2014-06-30       Impact factor: 4.897

5.  Prostate cancer survival estimates: An application with piecewise hazard function derivation.

Authors:  Atanu Bhattacharjee; Atul Budukh; Rajesh Dikshit
Journal:  South Asian J Cancer       Date:  2019 Jul-Sep

6.  Temporal Aspects of the Association between Exposure to the World Trade Center Disaster and Risk of Cutaneous Melanoma.

Authors:  Paolo Boffetta; David G Goldfarb; Rachel Zeig-Owens; Dana Kristjansson; Jiehui Li; Robert M Brackbill; Mark R Farfel; James E Cone; Janette Yung; Amy R Kahn; Baozhen Qiao; Maria J Schymura; Mayris P Webber; David J Prezant; Christopher R Dasaro; Andrew C Todd; Charles B Hall
Journal:  JID Innov       Date:  2021-10-13

7.  Personality links with lifespan in chimpanzees.

Authors:  Drew M Altschul; William D Hopkins; Elizabeth S Herrelko; Miho Inoue-Murayama; Tetsuro Matsuzawa; James E King; Stephen R Ross; Alexander Weiss
Journal:  Elife       Date:  2018-10-09       Impact factor: 8.140

8.  Correcting inaccurate background mortality in excess hazard models through breakpoints.

Authors:  Robert Darlin Mba; Juste Aristide Goungounga; Nathalie Grafféo; Roch Giorgi
Journal:  BMC Med Res Methodol       Date:  2020-10-29       Impact factor: 4.615

9.  Temporal association of prostate cancer incidence with World Trade Center rescue/recovery work.

Authors:  David G Goldfarb; Rachel Zeig-Owens; Dana Kristjansson; Jiehui Li; Robert M Brackbill; Mark R Farfel; James E Cone; Janette Yung; Amy R Kahn; Baozhen Qiao; Maria J Schymura; Mayris P Webber; Christopher R Dasaro; Moshe Shapiro; Andrew C Todd; David J Prezant; Paolo Boffetta; Charles B Hall
Journal:  Occup Environ Med       Date:  2021-09-10       Impact factor: 4.402

10.  Impact of healthcare services on thyroid cancer incidence among World Trade Center-exposed rescue and recovery workers.

Authors:  David G Goldfarb; Hilary L Colbeth; Molly Skerker; Mayris P Webber; David J Prezant; Christopher R Dasaro; Andrew C Todd; Dana Kristjansson; Jiehui Li; Robert M Brackbill; Mark R Farfel; James E Cone; Janette Yung; Amy R Kahn; Baozhen Qiao; Maria J Schymura; Paolo Boffetta; Charles B Hall; Rachel Zeig-Owens
Journal:  Am J Ind Med       Date:  2021-07-18       Impact factor: 3.079

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.